Cargando…
GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
Drug resistance constitutes one of the main obstacles for clinical recovery of acute myeloid leukemia (AML) patients. Therefore, the treatment of AML requires new strategies, such as adding a third drug. To address whether GATA2 could act as a regulator of chemotherapy resistance in human leukemia c...
Autores principales: | Yang, Li, Sun, Hanxiao, Cao, Yanan, Xuan, Binbin, Fan, Yingchao, Sheng, Huiming, Zhuang, Wenfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256934/ https://www.ncbi.nlm.nih.gov/pubmed/28114350 http://dx.doi.org/10.1371/journal.pone.0170630 |
Ejemplares similares
-
Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017) -
Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia
por: Tao, Yan-Fang, et al.
Publicado: (2015) -
Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy
por: Cartel, Maëlle, et al.
Publicado: (2020) -
Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia
por: Caldwell, John Timothy, et al.
Publicado: (2013) -
Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Hahn, Christopher N., et al.
Publicado: (2011)